-
S104897-100gA reagent used to modify cysteine residues in proteins to inhibit cysteine proteases.
-
S104897-1gA reagent used to modify cysteine residues in proteins to inhibit cysteine proteases.
-
S104897-25gA reagent used to modify cysteine residues in proteins to inhibit cysteine proteases.
-
S104897-5gA reagent used to modify cysteine residues in proteins to inhibit cysteine proteases.
-
S287571-1mgHighly potent inhibitor of SARS-CoV Spike (S) protein and ACE2 interaction.
-
S288439-100mgproduct description:P-141 is a specific MDM2 inhibitor. SP-141 promotes MDM2 auto-ubiquitination and degradation. SP-141 in potential for cancer research.
-
S288439-10mgproduct description:P-141 is a specific MDM2 inhibitor. SP-141 promotes MDM2 auto-ubiquitination and degradation. SP-141 in potential for cancer research.
-
S288439-250mgproduct description:P-141 is a specific MDM2 inhibitor. SP-141 promotes MDM2 auto-ubiquitination and degradation. SP-141 in potential for cancer research.
-
S288439-25mgproduct description:P-141 is a specific MDM2 inhibitor. SP-141 promotes MDM2 auto-ubiquitination and degradation. SP-141 in potential for cancer research.
-
S288439-50mgproduct description:P-141 is a specific MDM2 inhibitor. SP-141 promotes MDM2 auto-ubiquitination and degradation. SP-141 in potential for cancer research.
-
S288439-5mgproduct description:P-141 is a specific MDM2 inhibitor. SP-141 promotes MDM2 auto-ubiquitination and degradation. SP-141 in potential for cancer research.
-